quantitative
Analysis v1
Strong Support

For people with serious heart disease who are already taking cholesterol-lowering pills, adding one of two special drugs (evolocumab or alirocumab) can lower their chances of having a major heart problem—like a heart attack—by about 15% over a few years.

1
Pro
0
Against

Evidence from Studies

Supporting (1)

1

Community contributions welcome

The study looked at the same drugs in the same kind of patients and found they reduced heart problems by about 15%, just like the claim says.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.